薬物送達技術の世界市場予測(~2021):投与経路別(経口(固体)、経肺(噴霧器)、注射(装置)、経眼(液体)、局所(固体)、移植(活性)、経粘膜(経口))、患者ケア場所別...市場調査レポートについてご紹介

【英文タイトル】Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting (Hospital, ASC) - Global Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. – 25)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 32)

4 Premium Insights (Page No. – 36)
4.1 Topical Drug Delivery: Market Overview
4.2 Drug Delivery Technology Market, By Facility of Use
4.3 Solid Oral Drug Delivery Technology Market, By Dosage Form
4.4 Drug Delivery Technology Market, By Route of Administration
4.5 Geographical Snapshot of the Drug Delivery Technology Market

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Rising Prevalence of Chronic Diseases
5.3.2 Growth in the Biologics Market
5.3.3 Technological Advancement and New Product Launches
5.4 Restraints
5.4.1 Risk of Needlestick Injuries and Side Effects of Drugs
5.4.2 Product Recalls
5.5 Opportunities
5.5.1 Self-Administration and Home Care
5.5.2 Rising Demand for Biosimilars and Generic Drugs
5.5.2.1 Biosimilars
5.5.2.2 Generic Drugs
5.5.3 Focus on Overcoming Unmet Medical Needs
5.5.4 Emerging Markets
5.6 Challenges
5.6.1 Patent Expiry and Patent Cliff
5.6.2 Pricing Pressure

6 Regulatory Scenario (Page No. – 52)
6.1 Introduction
6.2 Drug Approval in the U.S.
6.3 Drug Approval in Europe

7 Drug Delivery Technology Market, By Route of Administration (Page No. – 55)
7.1 Introduction
7.2 Oral Drug Delivery
7.2.1 Solid Oral Drugs
7.2.1.1 Tablets
7.2.1.2 Capsules
7.2.1.3 Powders
7.2.1.4 Pills
7.2.2 Liquid Oral Drugs
7.2.2.1 Solutions
7.2.2.2 Syrups
7.2.3 Semi-Solid Oral Drugs
7.2.3.1 Gels
7.2.3.2 Emulsions
7.2.3.3 Elixirs
7.3 Pulmonary Drug Delivery
7.3.1 Formulations
7.3.2 Devices
7.3.2.1 Metered Dose Inhalers
7.3.2.2 Dry Powder Inhalers
7.3.2.3 Nebulizers
7.3.2.3.1 Jet Nebulizers
7.3.2.3.2 Ultrasonic Nebulizers
7.3.2.3.3 Soft Mist Nebulizers
7.4 Injectable Drug Delivery
7.4.1 Devices
7.4.1.1 Conventional Injection Devices
7.4.1.1.1 By Material
7.4.1.1.2 Glass
7.4.1.1.3 Plastic
7.4.1.1.4 By Product
7.4.1.1.4.1 Fillable Syringes
7.4.1.1.4.2 Prefilled Syringes
7.4.1.1.5 By Usability
7.4.1.1.5.1 Reusable Syringes
7.4.1.1.5.2 Disposable Syringes
7.4.1.2 Self-Injection Devices
7.4.1.2.1 Needle-Free Injectors
7.4.1.2.2 Autoinjectors
7.4.1.2.3 Pen Injectors
7.4.1.2.4 Wearable Injectors
7.4.1.3 Other Injector Devices
7.4.2 Formulations
7.4.2.1 Conventional Drug Delivery
7.4.2.2 Novel Drug Delivery Formulations
7.4.2.3 Long-Acting Injection Formulations
7.5 Ocular Drug Delivery
7.5.1 Formulations
7.5.1.1 Liquid Formulations
7.5.1.1.1 Eye Drops
7.5.1.1.2 Liquid Sprays
7.5.1.2 Semi-Solid Formulations
7.5.1.2.1 Gels
7.5.1.2.2 Eye Ointments
7.5.2 Ocular Devices
7.5.2.1 Drug-Coated Contact Lenses
7.5.2.2 Ocular Inserts
7.6 Nasal Drug Delivery
7.6.1 Nasal Drops
7.6.2 Nasal Sprays
7.6.3 Nasal Powders
7.6.4 Nasal Gels
7.7 Topical Drug Delivery
7.7.1 Formulations
7.7.1.1 Liquid Topical Drug Delivery
7.7.1.1.1 Solutions
7.7.1.1.2 Suspensions
7.7.1.2 Semi-Solid Topical Drug Delivery
7.7.1.2.1 Creams
7.7.1.2.2 Gels
7.7.1.2.3 Ointments
7.7.1.2.4 Pastes
7.7.1.2.5 Lotions
7.7.1.3 Solid Topical Drug Delivery
7.7.1.3.1 Suppositories
7.7.1.3.2 Powders
7.7.2 Devices (Transdermal Drug Delivery)
7.7.2.1 Transdermal Patches
7.7.2.2 Transdermal Gels
7.8 Implantable Drug Delivery
7.8.1 Active Implantable Drug Delivery
7.8.2 Passive Implantable Drug Delivery
7.9 Transmucosal Drug Delivery
7.9.1 Oral Transmucosal Drug Delivery
7.9.1.1 Buccal Drug Delivery
7.9.1.2 Sublingual Drug Delivery
7.9.2 Other Transmucosal Drug Delivery
7.9.2.1 Rectal Transmucosal Drug Delivery
7.9.2.2 Vaginal Transmucosal Drug Delivery

8 Drug Delivery Technology Market, By Facility of Use (Page No. – 134)
8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Centers/Clinics
8.4 Home Care Settings
8.5 Diagnostic Centers
8.6 Other Facilities of Use

9 Drug Delivery Technology Market, By Region (Page No. – 141)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Rest of Europe (RoE)
9.4 Asia
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia
9.5 Rest of the World

10 Competitive Landscape (Page No. – 170)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situations & Trends
10.3.1 Product Launches & Approvals
10.3.2 Partnerships, Agreements, and Collaborations
10.3.3 Acquisitions, Mergers, and Joint Ventures
10.3.4 Expansions

11 Company Profiles (Page No. – 178)
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Introduction
11.2 Johnson & Johnson Services, Inc.
11.3 Novartis AG
11.4 F. Hoffmann-La Roche Ltd.
11.5 Pfizer, Inc.
11.6 Bayer AG
11.7 Antares Pharma, Inc.
11.8 Becton, Dickinson and Company
11.9 Glaxosmithkline PLC
11.10 3M
11.11 Merck & Co., Inc.
11.12 Sanofi

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 227)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Other Recent Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Available Customizations
12.6 RT: Real-Time Market Intelligence
12.7 Related Reports
12.8 Author Details


【レポート販売概要】

■ タイトル:薬物送達技術の世界市場予測(~2021):投与経路別(経口(固体)、経肺(噴霧器)、注射(装置)、経眼(液体)、局所(固体)、移植(活性)、経粘膜(経口))、患者ケア場所別
■ 英文:Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting (Hospital, ASC) - Global Forecast to 2021
■ 発行日:2017年1月12日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-MD-3871
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。